LAUREN HARTING: Open Payments
NPI 1124128681 · HOBART, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,524 in 84 payments from 17 companies in 2025. Trend: 2023 $494 · 2024 $947 · 2025 $1,524
Food & beverage: $1,410Education: $114
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $328 |
| PFIZER INC. | 16 | $229 |
| Novo Nordisk Inc | 12 | $189 |
| Teva Pharmaceuticals USA, Inc. | 2 | $121 |
| Phathom Pharmaceuticals, Inc. | 8 | $101 |
| Astellas Pharma US Inc | 2 | $88 |
| Xeris Pharmaceuticals, Inc. | 4 | $84 |
| Otsuka America Pharmaceutical, Inc. | 3 | $69 |
| Exact Sciences Corporation | 3 | $52 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
Products named: NURTEC ODT, VRAYLAR, AUSTEDO XR, VOQUEZNA, UBRELVY, GVOKE HYPOPEN, Wegovy, QULIPTA.
Industry payments across IN — which companies pay providers there.
